EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

18F-FDG PET/CT guided salvage radiotherapy strategies for lymph-nodal relapses in gynecological cancers: SBRT vs ENRT

Andrei Fodor iD, Martina Midulla, Chiara Brombin, Paola M V Rancoita, Alice Bergamini, Paola Mangili, Miriam Torrisi, Lucia Perna, Emanuela Rabaiotti, Italo Dell'Oca, Chiara L Deantoni iD, Luca Bocciolone und 5 weitere

Tumori Journal · 2025

DOI: 10.1177/03008916251336055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tumori Journal, 2025. Verfasst von Andrei Fodor und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Genital Neoplasms, Female, Radiosurgery. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To identify outcome differences between extended nodal radiotherapy (ENRT) with simultaneous integrated boost (SIB) and stereotactic body radiotherapy (SBRT), performed with advanced radiotherapy techniques, both of which were 18F-Fluoro-Deoxy-Glucose (FDG) PET/CT guided, for lymph-node (LN) relapses of gynecological tumors, and to identify the most important determining factors.

Methods

Records of gynecologic patients treated in a single-institution with FDG PET/CT guided intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), or SBRT, were reviewed, and only patients at first salvage radiotherapy for LN relapses were considered. Local relapse-free- (LRFS), regional relapse-free- (RRFS), distant metastasis-free- (DMFS), disease-free-(DFS) and overall-survival (OS), as well as acute and late toxicity (with CTCAE v5.0 score), were determined.

Results

Fifty-eight patients (23 ENRT+SIB; 35 SBRT) treated for 178 LNs from February 2007-April 2023, were identified. Median biological equivalent dose (BED10) delivered to PET-positive LNs was 76.5 Gy (Interquartile range-IQR- 74.4;78.7) for ENRT, and 72 Gy (IQR 59.5;75.6) for SBRT. Median follow-up was 81.1(IQR 48.5; 117.2) and 37.0 (IQR 21.3; 58.4) months for ENRT and SBRT, respectively. Thirty-six-month estimated LRFS was 90.2% for ENRT and 82.6% for SBRT; RRFS was 69% and 63.4%, DMFS 26.1% and 44.3%, and OS 73.7% and 60.4%; no statistically significant differences were found between the two groups (logrank test, p= 0.29). ENRT recorded more acute (p⩽0.033), but not late, toxicities.

Conclusions

ENRT+SIB and SBRT for gynecological LN tumor relapses obtain similar results in terms of disease-free and OS, with fair toxicity. Prospective studies with higher patient numbers are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18Genital Neoplasms, FemaleRadiosurgerySalvage TherapyNeoplasm Recurrence, LocalLymphatic MetastasisRadiotherapy, Image-GuidedHumansFemaleMiddle AgedAgedAdultRadiotherapy, Intensity-ModulatedAged, 80 and overLymph NodesRetrospective Studies

Stichwörter der Autor:innen

Lymph node relapseextended nodal radiotherapy (ENRT)gynecologic tumorspositron emission tomography (PET) guidancesimultaneous integrated booststereotactic body radiotherapy

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Radiation Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • University Center for Statistics in the Biomedical Sciences, Vita-Salute San Raffaele University, Milan, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy.
  • Department of Oncologic Gynecology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Medical Physics, IRCCS San Raffaele Scientific Institute, Milan, Italy.

ORCID-Profile: Andrei Fodor, Chiara L Deantoni

Zitieren

APA

Fodor, A., Midulla, M., Brombin, C., Rancoita, P. M. V., Bergamini, A., Mangili, P., Torrisi, M., Perna, L., Rabaiotti, E., Dell'Oca, I., Deantoni, C. L., Bocciolone, L., Fiorino, C., Del Vecchio, A., Di Serio, M. S., Mangili, G., & Di Muzio, N. G. (2025). 18F-FDG PET/CT guided salvage radiotherapy strategies for lymph-nodal relapses in gynecological cancers: SBRT vs ENRT. Tumori Journal. https://doi.org/10.1177/03008916251336055

Vancouver

Fodor A, Midulla M, Brombin C, Rancoita PMV, Bergamini A, Mangili P, et al. 18F-FDG PET/CT guided salvage radiotherapy strategies for lymph-nodal relapses in gynecological cancers: SBRT vs ENRT. Tumori Journal. 2025. doi:10.1177/03008916251336055

BibTeX
@article{Fodor2025,
  author = {Fodor, Andrei and Midulla, Martina and Brombin, Chiara and Rancoita, Paola M V and Bergamini, Alice and Mangili, Paola and Torrisi, Miriam and Perna, Lucia and Rabaiotti, Emanuela and Dell'Oca, Italo and Deantoni, Chiara L and Bocciolone, Luca and Fiorino, Claudio and Del Vecchio, Antonella and Di Serio, Mariaclelia S and Mangili, Giorgia and Di Muzio, Nadia G},
  title = {18F-FDG PET/CT guided salvage radiotherapy strategies for lymph-nodal relapses in gynecological cancers: SBRT vs ENRT},
  journal = {Tumori Journal},
  year = {2025},
  doi = {10.1177/03008916251336055}
}
Kostenlos starten →